Michael Olson

发表

Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways.

S. Kridel, A. Koong, Jiangbin Ye, 2008, Cancer research.

Role of immunotherapy in Ewing sarcoma

T. Luetkens, D. Atanackovic, Michael L. Olson, 2020, Journal for ImmunoTherapy of Cancer.

Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells

A. Letai, J. Ryan, Michael L. Olson, 2023, Cell death & disease.

Targeting the tumor microenvironment of Ewing sarcoma.

T. Luetkens, D. Atanackovic, Michael L. Olson, 2021, Immunotherapy.

Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma.

A. Koong, D. Bouley, N. Denko, 2011, Blood.

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing fratricide and antigen-negative tumor escape while preserving anti-tumor activity

T. Luetkens, D. Atanackovic, A. Welm, 2021, bioRxiv.

Fast off-rate CD229 chimeric antigen receptor T cells efficiently target multiple myeloma, spare T cells, and exhibit reduced trogocytosis

David P Ng, J. Panse, T. Luetkens, 2021 .

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

T. Luetkens, D. Atanackovic, Michael L. Olson, 2019, Oncoimmunology.

Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity

T. Luetkens, D. Atanackovic, Carol S. Lim, 2023, Science Translational Medicine.

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion

T. Luetkens, D. Atanackovic, A. Welm, 2022, Leukemia.

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide

J. Panse, T. Luetkens, D. Atanackovic, 2020, Nature Communications.

The role of surface molecule CD229 in Multiple Myeloma.

T. Luetkens, D. Atanackovic, Michael L. Olson, 2019, Clinical immunology.